
    
      Drug: SHR-1210 + Apatinib +Fluzoparib SHR-1210 will be administered as an intravenous
      infusion, Apatinib tablets will be given orally, Fluzoparib capsule will be given orally 28
      days per cycle, until disease progression or unacceptable toxicity.

      Treatment group ï¼š PD-1 antibody SHR-1210 combination with aptinib and fluzoparib
    
  